Immunotherapy and Targeted Therapy for Advanced Gastroesophageal Cancers — Microlearning Activity 2: Proceedings from a Session Held Adjunct to the 2026 ASCO GI Cancers Symposium
Featuring perspectives from Dr Jaffer A Ajani,
Dr Samuel J Klempner, Dr Rutika Mehta and Dr John Strickler,
moderated by Dr Klempner, including the following topics:
Older patient with metastatic claudin 18.2-positive
gastroesophageal (GE) cancer (0:00)
Management of nausea and vomiting with zolbetuximab for GE
cancer (9:37)
Younger patient with metastatic claudin 18.2-positive,
PD-L1-positive GE cancer (15:34)
Featuring the video recorded proceedings of events held in conjunction with important scientific symposia, live webcasts and closed meetings featuring the perspectives of renowned clinical investigators, these videos provide an overview of important advances in the management of a number of solid tumors and hematologic cancers.